HDAC9 and colorectal cancer: More recently, functional efficacy of the microbial SCFA butyrate as a HDAC inhibitor in colorectal cancer was linked to increased histone crotonylation via inhibition of HDAC2, potentially linking selective HDAC inhibition by the gut microbiota to inhibition of tumorigenesis [25].